Refinery has not recorded this company's share classes yet, so ownership cannot be shown across them.
| Class | Shares outstanding | Held by institutions | Votes a share | Economics a share |
|---|---|---|---|---|
| EPRX | — | — | 1 vote | 1 |
A trend across this company's share classes isn't available yet: each quarter's 13F filings add up shares of classes that differ in economics and votes.
Sign up to see all 5.
Sign up to see all 5.
No insider has filed a notice of proposed sale (Form 144) for EUPRAXIA PHARMACEUTICALS INC. in the last 12 months.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
BG
Beutel, Goodman & Co Ltd.
|
3.6M | — | −38.6K (−1.1%) | Q3 '25 | 0.2% | |
|
Shares held by quarter
|
||||||
|
AA
Affinity Asset Advisors, LLC
|
1.7M | — | +61.0K (+3.8%) | Q3 '25 | 0.5% | |
|
Shares held by quarter
Peak holding1.7M (Q2'26)
Change over 8 quarters+1.7M
|
||||||
28 more super investors behind a free account
See every manager holding EUPRAXIA PHARMACEUTICALS INC., how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
FN
Fidelity Concord Street Trust
|
$257K | 36.2K | — | 0.00% | May 31, 2026 |
|
BA
Blackstone Alternative Investment Funds
|
$1.98K | 300 | — | 0.00% | June 30, 2026 |
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
JS
Joseph S. Freedman
5%+ holder
13D · 9.0%
|
5.8M | — | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
Disclosed stake13D · 9.0%
|
||||||
Loading...